Global Alcoholic Hepatitis Treatment Market Growth Analysis 2024, Forecast To 2033

8 Mar, 2024

The alcoholic hepatitis treatment market size has grown strongly in recent years. It will grow from $2.95 billion in 2023 to $3.18 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to high prevalence of alcohol abuse, increased awareness and diagnostics, government initiatives on alcoholism, increased healthcare expenditure, public health campaigns. The alcoholic hepatitis treatment market size is expected to see strong growth in the next few years. It will grow to $4.32 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to emerging therapies and drug pipeline, precision medicine approaches, growing understanding of disease pathogenesis, increasing focus on liver health, public health policies addressing alcohol abuse. Major trends in the forecast period include personalized medicine approaches, liver transplantation trends, telemedicine and remote monitoring, collaborative research initiatives, innovative drug solutions.

Global Alcoholic Hepatitis Treatment Market Key Driver

The increased prevalence of liver diseases caused by alcohol consumption, with predictions indicating significant rises in alcohol-related liver disease-related deaths, liver failure cases, and liver cancer by 2040 according to the National Library of Medicine, is expected to propel the growth of the alcoholic hepatitis treatment market. Alcoholic liver disease results in liver function damage, necessitating treatments such as alcoholic hepatitis treatment, particularly for patients with severe liver inflammation who may require therapy in a hospital setting.

Get A Free Sample Of The Global Alcoholic Hepatitis Treatment Market Report

Global Alcoholic Hepatitis Treatment Market Segments

The alcoholic hepatitis treatment market covered in this report is segmented –
1) Treatment:Drug Treatment, Stem Cell Therapy
2) Drug Class:Corticosteroids, Hemorheologic Agents, Monoclonal Antibodies, Anabolic Steroids, Other Drug Classes
3) Route of Administration:Oral, Injectable
4) Application:Hospital, Clinic, Private Treatment Center
By Geography: The countries covered in the alcoholic hepatitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. North America was the largest region in the alcoholic hepatitis treatment market in 2023. It is expected to be the fastest-growing region in the forecast period. The regions covered in the alcoholic hepatitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Major Alcoholic Hepatitis Treatment Industry Players

Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Novartis AG; Sanofi PLC; Bristol-Myers Squibb Company; GlaxoSmithKline Plc; Torrent Pharmaceuticals Ltd.; Takeda Pharmaceutical Company Limited; Gilead Sciences Inc.; Merck KGaA; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; AstraZeneca Plc; Cadila Pharmaceuticals; Sun Pharmaceutical Industries Ltd.; Mylan Inc.; Dr. Reddy’s Laboratories Ltd.; Cipla Ltd.; Hikma Pharmaceuticals PLC; Mallinckrodt Pharmaceuticals; Alkermes PLC; Intercept Pharmaceuticals Inc.; Apotex Inc.; Durect Corp.

Get The Full Global Alcoholic Hepatitis Treatment Market Report

Alcoholic Hepatitis Treatment Market Overview

Alcoholic hepatitis treatment refers to treatments provided for giving up alcohol and receiving treatments to lessen the symptoms of liver damage. Alcoholic hepatitis is treated in part by abstaining from alcohol and receiving therapy to minimize the warning signs and symptoms of liver damage.